Absence of nonhematopoietic MHC class II expression protects mice from experimental autoimmune myocarditis

European Journal of Immunology

Volumn 46, Issue 3, 2016, Pages 656-664

  Thelemann, Christoph ^a   Haller, Sergio ^a   Blyszczuk, Przemyslaw ^b   Kania, Gabriela ^c   Rosa, Muriel ^a   Eriksson, Urs ^b   Rotman, Samuel ^d   Reith, Walter ^e   Acha Orbea, Hans ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

CD4+ T cells; Endothelial antigen presentation; Experimental autoimmune myocarditis (EAM); Interferon ; MHC class II

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYOSIN HEAVY CHAIN ALPHA; AUTOANTIGEN; HLA ANTIGEN CLASS 2; MHC CLASS II TRANSACTIVATOR PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; FEMALE; HEART MUSCLE CELL; IMMUNIZATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; AUTOIMMUNE DISEASE; CARDIAC MUSCLE; DISEASE MODEL; ENDOTHELIUM; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MYOCARDITIS; PATHOLOGY; PROMOTER REGION; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENDOTHELIUM; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MYOCARDITIS; MYOCARDIUM; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; TRANS-ACTIVATORS;

EID: 84959331833     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545945     Document Type: Article

References (45)

1. Feldman, A. M. and McNamara, D., Myocarditis. N. Engl. J. Med. 2000. 343: 1388-1398.
2. Smith, S. C. and Allen, P. M., Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991. 147: 2141-2147.
3. Pummerer, C. L., Luze, K., Grassl, G., Bachmaier, K., Offner, F., Burrell, S. K., Lenz, D. M. et al., Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Invest. 1996. 97: 2057-2062.
4. Neu, N., Rose, N. R., Beisel, K. W., Herskowitz, A., Gurri-Glass, G. and Craig, S. W., Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 1987. 139: 3630-3636.
5. Eriksson, U., Ricci, R., Hunziker, L., Kurrer, M. O., Oudit, G. Y., Watts, T. H., Sonderegger, I. et al., Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 2003. 9: 1484-1490.
6. Afanasyeva, M., Georgakopoulos, D., Fairweather, D., Caturegli, P., Kass, D. A. and Rose, N. R., Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon-gamma-knockout mice. Circulation 2004. 110: 2910-2917.
7. Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K. et al., Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 2010. 106: 1646-1655.
8. Lv, H., Havari, E., Pinto, S., Gottumukkala, R. V., Cornivelli, L., Raddassi, K., Matsui, T. et al., Impaired thymic tolerance to alpha-myosin directs autoimmunity to the heart in mice and humans. J. Clin. Invest. 2011. 121: 1561-1573.
9. Smith, S. C. and Allen, P. M., Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc. Natl. Acad. Sci. U S A 1992. 89: 9131-9135.
10. Eriksson, U., Kurrer, M. O., Sonderegger, I., Iezzi, G., Tafuri, A., Hunziker, L., Suzuki, S. et al., Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med. 2003. 197: 323-331.
11. Duraes, F. V., Thelemann, C., Sarter, K., Acha-Orbea, H., Hugues, S. and Reith, W., Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: facts and fiction. Tissue Antigens 2013. 82: 1-15.
12. Reith, W., LeibundGut-Landmann, S. and Waldburger, J. M., Regulation of MHC class II gene expression by the class II transactivator. Nat. Rev. Immunol. 2005. 5: 793-806.
13. Caforio, A. L., Stewart, J. T., Bonifacio, E., Burke, M., Davies, M. J., McKenna, W. J. and Bottazzo, G. F., Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J. Autoimmun. 1990. 3: 187-200.
14. Hufnagel, G. and Maisch, B., Expression of MHC class I and II antigens and the Il-2 receptor in rejection, myocarditis and dilated cardiomyopathy. Eur. Heart. J. 1991. 12 (Suppl D): 137-140.
15. Li, W. M., Liu, W., Gao, C. and Zhou, B. G., Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. Immunol. Cell. Biol. 2006. 84: 274-280.
16. Yang, Y. Z., Jin, P. Y., Guo, Q., Wang, Q. D., Li, Z. S., Ye, Y. C., Shan, Y. F. et al., Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha- and gamma-interferon in patients with Coxsackie B viral myocarditis. Chin. Med. J. 1990. 103: 304-307.
17. Perez Leiros, C., Goren, N., Sterin-Borda, L. and Borda, E. S., Myocardial dysfunction in an experimental model of autoimmune myocarditis: role of IFN-gamma. Neuroimmunomodulation 1997. 4: 91-97.
18. Smith, S. C. and Allen, P. M., Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ. Res. 1992. 70: 856-863.
19. Reifenberg, K., Lehr, H. A., Torzewski, M., Steige, G., Wiese, E., Kupper, I., Becker, C. et al., Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am. J. Pathol. 2007. 171: 463-472.
20. Nindl, V., Maier, R., Ratering, D., De Giuli, R., Zust, R., Thiel, V., Scandella, E. et al., Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy. Eur. J. Immunol. 2012. 42: 2311-2321.
21. Afanasyeva, M., Georgakopoulos, D., Belardi, D. F., Bedja, D., Fairweather, D., Wang, Y., Kaya, Z. et al., Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci. U S A 2005. 102: 180-185.
22. Eriksson, U., Kurrer, M. O., Bingisser, R., Eugster, H. P., Saremaslani, P., Follath, F., Marsch, S. et al., Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 2001. 103: 18-21.
23. Cihakova, D. and Rose, N. R., Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008. 99: 95-114.
24. Waldburger, J. M., Suter, T., Fontana, A., Acha-Orbea, H. and Reith, W., Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J. Exp. Med. 2001. 194: 393-406.
25. Thelemann, C., Eren, R. O., Coutaz, M., Brasseit, J., Bouzourene, H., Rosa, M., Duval, A. et al., Interferon-gamma induces expression of MHC class II on intestinal epithelial cells and protects mice from colitis. PLoS One 2014. 9: e86844.
26. Irla, M., Hugues, S., Gill, J., Nitta, T., Hikosaka, Y., Williams, I. R., Hubert, F. X. et al., Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity. Immunity 2008. 29: 451-463.
27. Afanasyeva, M., Georgakopoulos, D. and Rose, N. R., Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev. 2004. 3: 476-486.
28. Kaneko, N., Matsuda, R., Toda, M. and Shimamoto, K., Three-dimensional reconstruction of the human capillary network and the intramyocardial micronecrosis. Am. J. Physiol. Heart. Circ. Physiol. 2011. 300: H754-H761.
29. Okura, Y., Takeda, K., Honda, S., Hanawa, H., Watanabe, H., Kodama, M., Izumi, T. et al., Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ. Res. 1998. 82: 1035-1042.
30. Maier, R., Miller, S., Kurrer, M., Krebs, P., de Giuli, R., Kremer, M., Scandella, E. et al., Quantification and characterization of myosin peptide-specific CD4+ T cells in autoimmune myocarditis. J. Immunol. Methods 2005. 304: 117-125.
31. Barin, J. G., Talor, M. V., Baldeviano, G. C., Kimura, M., Rose, N. R. and Cihakova, D., Mechanisms of IFNgamma regulation of autoimmune myocarditis. Exp. Mol. Pathol. 2010. 89: 83-91.
32. Goser, S., Ottl, R., Brodner, A., Dengler, T. J., Torzewski, J., Egashira, K., Rose, N. R. et al., Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 2005. 112: 3400-3407.
33. Song, H. K., Noorchashm, H., Lin, T. H., Moore, D. J., Greeley, S. A., Caton, A. J. and Naji, A., Specialized CC-chemokine secretion by Th1 cells in destructive autoimmune myocarditis. J. Autoimmun. 2003. 21: 295-303.
34. Kania, G., Siegert, S., Behnke, S., Prados-Rosales, R., Casadevall, A., Luscher, T. F., Luther, S. A. et al., Innate signaling promotes formation of regulatory nitric oxide-producing dendritic cells limiting T-cell expansion in experimental autoimmune myocarditis. Circulation 2013. 127: 2285-2294.
35. Turesson, C., Endothelial expression of MHC class II molecules in autoimmune disease. Curr. Pharm. Des. 2004. 10: 129-143.
36. Kelchtermans, H., Billiau, A. and Matthys, P., How interferon-gamma keeps autoimmune diseases in check. Trends Immunol. 2008. 29: 479-486.
37. Afanasyeva, M., Wang, Y., Kaya, Z., Stafford, E. A., Dohmen, K. M., Sadighi Akha, A. A. and Rose, N. R., Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001. 104: 3145-3151.
38. Eriksson, U., Kurrer, M. O., Sebald, W., Brombacher, F. and Kopf, M., Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J. Immunol. 2001. 167: 5464-5469.
39. Blyszczuk, P., Berthonneche, C., Behnke, S., Glonkler, M., Moch, H., Pedrazzini, T., Luscher, T. F. et al., Nitric oxide synthase 2 is required for conversion of pro-fibrogenic inflammatory CD133(+) progenitors into F4/80(+) macrophages in experimental autoimmune myocarditis. Cardiovasc. Res. 2013. 97: 219-229.
40. Rangachari, M., Mauermann, N., Marty, R. R., Dirnhofer, S., Kurrer, M. O., Komnenovic, V., Penninger, J. M. et al., T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 2006. 203: 2009-2019.
41. Sonderegger, I., Rohn, T. A., Kurrer, M. O., Iezzi, G., Zou, Y., Kastelein, R. A., Bachmann, M. F. et al., Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis. Eur. J. Immunol. 2006. 36: 2849-2856.
42. Valaperti, A., Marty, R. R., Kania, G., Germano, D., Mauermann, N., Dirnhofer, S., Leimenstoll, B. et al., CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis. J. Immunol. 2008. 180: 2686-2695.
43. Barin, J. G., Baldeviano, G. C., Talor, M. V., Wu, L., Ong, S., Fairweather, D., Bedja, D. et al., Fatal eosinophilic myocarditis develops in the absence of IFN-gamma and IL-17A. J. Immunol. 2013. 191: 4038-4047.
44. Wu, L., Ong, S., Talor, M. V., Barin, J. G., Baldeviano, G. C., Kass, D. A., Bedja, D. et al., Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 2014. 211: 1449-1464.
45. Cai, G., Zhang, J., Liu, L. and Shen, Q., Successful treatment of experimental autoimmune myocarditis by adenovirus-mediated gene transfer of antisense CIITA. J. Mol. Cell. Cardiol. 2005. 38: 593-605.